Cargando…

Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury

Systemic administration of human amnion epithelial cells (hAECs) was recently shown to reduce neuropathology and improve functional recovery following ischemic stroke in both mice and marmosets. Given the significant neuropathological overlap between ischemic stroke and traumatic brain injury (TBI),...

Descripción completa

Detalles Bibliográficos
Autores principales: Ah Kim, Hyun, Semple, Bridgette D., Dill, Larissa K., Pham, Louise, Dworkin, Sebastian, Zhang, Shenpeng R., Lim, Rebecca, Sobey, Christopher G., McDonald, Stuart J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474600/
https://www.ncbi.nlm.nih.gov/pubmed/34589854
http://dx.doi.org/10.1016/j.bbih.2020.100072
_version_ 1784575257183518720
author Ah Kim, Hyun
Semple, Bridgette D.
Dill, Larissa K.
Pham, Louise
Dworkin, Sebastian
Zhang, Shenpeng R.
Lim, Rebecca
Sobey, Christopher G.
McDonald, Stuart J.
author_facet Ah Kim, Hyun
Semple, Bridgette D.
Dill, Larissa K.
Pham, Louise
Dworkin, Sebastian
Zhang, Shenpeng R.
Lim, Rebecca
Sobey, Christopher G.
McDonald, Stuart J.
author_sort Ah Kim, Hyun
collection PubMed
description Systemic administration of human amnion epithelial cells (hAECs) was recently shown to reduce neuropathology and improve functional recovery following ischemic stroke in both mice and marmosets. Given the significant neuropathological overlap between ischemic stroke and traumatic brain injury (TBI), we hypothesized that a similar hAEC treatment regime would also improve TBI outcomes. Male mice (12 weeks old, n ​= ​40) were given a sham injury or moderate severity TBI by controlled cortical impact. At 60 ​min post-injury, mice were given a single tail vein injection of either saline (vehicle) or 1 ​× ​10(6) hAECs suspended in saline. At 24 ​h post-injury, mice were assessed for locomotion and anxiety using an open field, and sensorimotor ability using a rotarod. At 48 ​h post-injury, brains were collected for analysis of immune cells via flow cytometry, or histological evaluation of lesion volume and hAEC penetration. To assess the impact of TBI and hAECs on lymphoid organs, spleen and thymus weights were determined. Treatment with hAECs did not prevent TBI-induced sensorimotor deficits at 24 ​h post-injury. hAECs were detected in the injured brain parenchyma; however, lesion volume was not altered by hAEC treatment. Robust increases in several leukocyte populations in the ipsilateral hemisphere of TBI mice were found when compared to sham mice at 48 ​h post-injury; however, hAEC treatment did not alter brain immune cell numbers. Both TBI and hAEC treatment were found to increase spleen weight. Taken together, these findings indicate that—unlike in ischemic stroke—treatment with hAEC was unable to prevent immune cell infiltration and sensorimotor deficits in the acute stages following controlled cortical impact in mice. Although further investigations are required, our data suggests that the lack of hAEC-induced neuroprotection in the current study may be explained by the differential splenic contributions to neuropathology between these brain injury models.
format Online
Article
Text
id pubmed-8474600
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-84746002021-09-28 Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury Ah Kim, Hyun Semple, Bridgette D. Dill, Larissa K. Pham, Louise Dworkin, Sebastian Zhang, Shenpeng R. Lim, Rebecca Sobey, Christopher G. McDonald, Stuart J. Brain Behav Immun Health Full Length Article Systemic administration of human amnion epithelial cells (hAECs) was recently shown to reduce neuropathology and improve functional recovery following ischemic stroke in both mice and marmosets. Given the significant neuropathological overlap between ischemic stroke and traumatic brain injury (TBI), we hypothesized that a similar hAEC treatment regime would also improve TBI outcomes. Male mice (12 weeks old, n ​= ​40) were given a sham injury or moderate severity TBI by controlled cortical impact. At 60 ​min post-injury, mice were given a single tail vein injection of either saline (vehicle) or 1 ​× ​10(6) hAECs suspended in saline. At 24 ​h post-injury, mice were assessed for locomotion and anxiety using an open field, and sensorimotor ability using a rotarod. At 48 ​h post-injury, brains were collected for analysis of immune cells via flow cytometry, or histological evaluation of lesion volume and hAEC penetration. To assess the impact of TBI and hAECs on lymphoid organs, spleen and thymus weights were determined. Treatment with hAECs did not prevent TBI-induced sensorimotor deficits at 24 ​h post-injury. hAECs were detected in the injured brain parenchyma; however, lesion volume was not altered by hAEC treatment. Robust increases in several leukocyte populations in the ipsilateral hemisphere of TBI mice were found when compared to sham mice at 48 ​h post-injury; however, hAEC treatment did not alter brain immune cell numbers. Both TBI and hAEC treatment were found to increase spleen weight. Taken together, these findings indicate that—unlike in ischemic stroke—treatment with hAEC was unable to prevent immune cell infiltration and sensorimotor deficits in the acute stages following controlled cortical impact in mice. Although further investigations are required, our data suggests that the lack of hAEC-induced neuroprotection in the current study may be explained by the differential splenic contributions to neuropathology between these brain injury models. Elsevier 2020-04-19 /pmc/articles/PMC8474600/ /pubmed/34589854 http://dx.doi.org/10.1016/j.bbih.2020.100072 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Full Length Article
Ah Kim, Hyun
Semple, Bridgette D.
Dill, Larissa K.
Pham, Louise
Dworkin, Sebastian
Zhang, Shenpeng R.
Lim, Rebecca
Sobey, Christopher G.
McDonald, Stuart J.
Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title_full Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title_fullStr Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title_full_unstemmed Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title_short Systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
title_sort systemic treatment with human amnion epithelial cells after experimental traumatic brain injury
topic Full Length Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474600/
https://www.ncbi.nlm.nih.gov/pubmed/34589854
http://dx.doi.org/10.1016/j.bbih.2020.100072
work_keys_str_mv AT ahkimhyun systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT semplebridgetted systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT dilllarissak systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT phamlouise systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT dworkinsebastian systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT zhangshenpengr systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT limrebecca systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT sobeychristopherg systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury
AT mcdonaldstuartj systemictreatmentwithhumanamnionepithelialcellsafterexperimentaltraumaticbraininjury